Home Magazine Past Issues Feature

Virtual Drug Discovery: The New Paradigm

Written by
In February, Pfizer announced the closing of its R&D center in Sandwich, United Kingdom. Once the diamond of their drug development, the facility covered 80…

Reinvigorating R&D

Written by
Improving productivity and reinvigorating innovation in biopharma R&D The biopharmaceutical industry is struggling. It is facing a raft of issues — R&D productivity is falling,…

Founded On Research That...“Brought The House Down”

Written by
For Epizyme, a Cambridge, MA-based biopharma company established almost three years ago, 2011 is already a good year. In early January, the company announced it…

The Pharma Veteran

Written by
Blockbusters, megamergers, government investigations — Fred Hassan has experienced them all during his nearly 40-year career. In this exclusive interview, he gives some advice to…